Bull
$37.14
情景价格
$20.330
-0.990 (-4.87%)收盘时
Semler Scientific, Inc. is engaged in developing and marketing technology products and services to healthcare providers to combat chronic diseases. The Company's flagship product, QuantaFlo, which is patented and cleared by the United States Food and Drug Administration (FDA), is a rapid point-of-care test that measures arterial blood flow in the extremities. The QuantaFlo test aids in the diagnosis of cardiovascular diseases, such as peripheral arterial disease (PAD), and the Company is seeking a new 510(k) clearance for expanded-indications. QuantaFlo is used by healthcare providers to evaluate their patient's risk of mortality and major adverse cardiovascular events (MACE). QuantaFlo features a sensor clamp that is placed on the toe or finger. A blood flow waveform is instantaneously constructed by its software algorithm. The Company delivers QuantaFlo directly to its customers. The Company also invests in bitcoin and has adopted Bitcoin as its primary treasury asset.
Maxim
$80
2025-09-19
Maxim
2025-09-19
目标价
$80
Maxim
$95
2025-07-09
Maxim
2025-07-09
目标价
$95
Lake Street
$71
2025-01-24
Lake Street
2025-01-24
目标价
$71
B. Riley Securities
$45
2022-11-02
B. Riley Securities
2022-11-02
目标价
$45
B. Riley Securities
$60
2022-05-03
B. Riley Securities
2022-05-03
目标价
$60
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

Strive, Inc. Completes Semler Scientific Acquisition, Holds 12,797.9 Bitcoin

Crypto Treasury Stocks, Including Strategy, Encounter a Risky Downward Trend: Ways to Overcome It.

MSTR Stock: Strategies and Other Crypto Reserves Encounter a Risky Downward Trend.

Semler Scientific to be Sold to Strive, Shareholders to Receive 21.05 Shares Each

Wohl & Fruchter Investigates Semler-Strive Merger Fairness Amid Fixed Exchange Ratio Concerns
Semler Scientific, Inc. is engaged in developing and marketing technology products and services to healthcare providers to combat chronic diseases. The Company's flagship product, QuantaFlo, which is patented and cleared by the United States Food and Drug Administration (FDA), is a rapid point-of-care test that measures arterial blood flow in the extremities. The QuantaFlo test aids in the diagnosis of cardiovascular diseases, such as peripheral arterial disease (PAD), and the Company is seeking a new 510(k) clearance for expanded-indications. QuantaFlo is used by healthcare providers to evaluate their patient's risk of mortality and major adverse cardiovascular events (MACE). QuantaFlo features a sensor clamp that is placed on the toe or finger. A blood flow waveform is instantaneously constructed by its software algorithm. The Company delivers QuantaFlo directly to its customers. The Company also invests in bitcoin and has adopted Bitcoin as its primary treasury asset. It operates in the Healthcare sector (ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS industry).
1 analysts cover SMLR: 1 rate it Buy, 0 Hold and 0 Sell. The average price target is 51.00.
本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。